EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissue

Annalise Schweickart iD, Richa Batra, Kevin Huynh, Collette Blach, Alexandra Kueider-Paisley, Joseph S Reddy, David A Bennett, Peter J Meikle, Bin Zhang, Philip L De Jager, Laura Heath, Jaclyn Beck und 8 weitere

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 13.10.2026. Verfasst von Annalise Schweickart und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems and Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Ceramides, Sphingolipids. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Metabolic dysregulation is a hallmark of Alzheimer's disease (AD), with numerous studies characterizing metabolic pathways associated with AD onset and progression. A limitation of these studies has been a focus on non‐Hispanic white participants. Despite evidence that AD prevalence, progression, and biomarkers differ across ethnoracial groups, it remains unclear whether previously identified metabolic dysregulation in AD brains generalizes across populations. METHODS We analyzed metabolomics data from 547 postmortem brain tissue samples of Hispanic American, Non‐Hispanic African American, and White subjects, providing the largest multiethnic AD brain cohort to date. A metabolome‐wide association study examined how relationships between metabolite abundance and AD neuropathology varied by ethnoracial group. RESULTS Forty‐eight metabolites exhibited significant heterogeneity with tau pathology (Braak stage), with enrichment in tricarboxylic‐acid‐cycle intermediates and sphingolipid‐ceramide pathway lipids, and with metabolite–tau associations driven predominantly by the Hispanic American and non‐Hispanic White groups. DISCUSSION These findings reveal ethnoracial‐specific metabolic signatures of tau pathology and emphasize the need to evaluate emerging therapeutic targets across diverse groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainCeramidesSphingolipidstau ProteinsAgedAged, 80 and overFemaleHumansMaleBlack or African AmericanHispanic or LatinoMetabolomicsWhite

Stichwörter der Autor:innen

AMP‐AD Diverse CohortsAPOE4Alzheimer's diseaseBraak stageLipid metabolismacetylcholinebrain metabolomicsceramidedipeptidesdorsolateral prefrontal cortexethnoracial differencesmetabolic heterogeneitymultiethnic cohortneurodegenerationpopulation health disparities

Substanzen

CeramidesSphingolipidstau Proteins

Autor:innen und Institutionen

  • Department of Systems and Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.
  • Buck Institute for Research on Aging, Novato, California, USA.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Baker Department of Cardiovascular Research Translation and Implementation, La Trobe University, Bundoora, Victoria, Australia.
  • Department of Psychiatry and Behavioral Sciences, Duke Institute for Brain Sciences and Department of Medicine, Duke University, Durham, North Carolina, USA.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

ORCID-Profile: Annalise Schweickart, Jan Krumsiek

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • National Institute on Aging

Zitieren

APA

Schweickart, A., Batra, R., Huynh, K., Blach, C., Kueider-Paisley, A., Reddy, J. S., Bennett, D. A., Meikle, P. J., Zhang, B., De Jager, P. L., Heath, L., Beck, J., Scanlan, J., Seyfried, N. T., Dickson, D. W., Ertekin-Taner, N., Alzheimer's Disease Metabolomics Consortium, Kaddurah-Daouk, R., Arnold, M., & Krumsiek, J. (2026). Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissue. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71690

Vancouver

Schweickart A, Batra R, Huynh K, Blach C, Kueider-Paisley A, Reddy JS, et al. Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissue. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71690

BibTeX
@article{Schweickart2026,
  author = {Schweickart, Annalise and Batra, Richa and Huynh, Kevin and Blach, Collette and Kueider-Paisley, Alexandra and Reddy, Joseph S and Bennett, David A and Meikle, Peter J and Zhang, Bin and De Jager, Philip L and Heath, Laura and Beck, Jaclyn and Scanlan, Jo and Seyfried, Nicholas T and Dickson, Dennis W and Ertekin-Taner, Nilüfer and Alzheimer's Disease Metabolomics Consortium, Alzheimer's Disease Metabolomics Consortium and Kaddurah-Daouk, Rima and Arnold, Matthias and Krumsiek, Jan},
  title = {Sphingolipid and ceramide associations with tau pathology vary across diverse ethnoracial groups in postmortem brain tissue},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71690}
}
Kostenlos starten →